Mannin Research

Mannin Research

  • Founded: 2012
  • Location: Toronto, ON
  • Employee range: 1 - 10
  • Clinical stage: Clin0
  • Therapy area: Glaucoma
  • Drug types: OPH, NPH
  • Lead product: Man-01
  • Product link:
  • Funding: 10-100M

job board

Short description:

Vascular Therapies

Drug notes:

Undisclosed RD cystic kidney disease

Long description:

Mannin Research is developing therapeutics for vascular diseases. High intraocular eye pressure (IOP) is one of the main causes of glaucoma. Using their proprietary research platform, Mannin is developing a unique molecule that can be administered via eye drops to reduce IOP. This lead indication is being tested for treatment of primary open-angle glaucoma. In addition, Mannin is researching therapeutics that could treat cystic kidney disease, pediatric glaucoma and inflammation. This will enable Mannin to establish a deep pipeline of novel therapeutics.


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy